SCHEMBL1623931

SCHEMBL1623931

Cc1ccc2c(N3CCN(C(=O)[C@H](O)CC(C)C)C(O)C3)nc(-c3ccccc3O)nc2c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.43
MEN1 O00255 1/20 0.43
CHEK2 O96017 4/20 0.43
SMAD3 P84022 1/20 0.43
ALDH1A1 P00352 6/20 0.41
MAPT P10636 4/20 0.41
TSHR P16473 2/20 0.41
L3MBTL1 Q9Y468 2/20 0.41
KDM4E B2RXH2 4/20 0.35
HSD17B10 Q99714 3/20 0.35
HPGD P15428 3/20 0.35
TDP1 Q9NUW8 2/20 0.35
NPSR1 Q6W5P4 1/20 0.35
HRH4 Q9H3N8 1/20 0.35
USP2 O75604 1/20 0.35
LMNA P02545 1/20 0.35
MAPK1 P28482 1/20 0.35
BRD4 O60885 1/20 0.35
SMARCA2 P51531 1/20 0.35
SMARCA4 P51532 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1623930 1.00 KMT2A (0.43) KMT2AMEN1CHEK2SMAD3ALDH1A1
SCHEMBL1623833 0.91 MEN1 (0.42) KMT2AMEN1CHEK2SMAD3ALDH1A1
SCHEMBL1623832 0.91 MEN1 (0.42) KMT2AMEN1CHEK2SMAD3ALDH1A1
SCHEMBL1621281 0.87 MEN1 (0.49) KMT2AMEN1CHEK2SMAD3ALDH1A1
SCHEMBL1621278 0.87 MEN1 (0.49) KMT2AMEN1CHEK2SMAD3ALDH1A1
SCHEMBL1623555 0.87 MEN1 (0.49) KMT2AMEN1CHEK2SMAD3ALDH1A1
Hydrochloric Acid SCHEMBL1623542 0.86 MEN1 (0.48) KMT2AMEN1CHEK2SMAD3ALDH1A1
Hydrochloric Acid SCHEMBL1623544 0.86 MEN1 (0.48) KMT2AMEN1CHEK2SMAD3ALDH1A1
Hydrochloric Acid SCHEMBL1624026 0.86 MEN1 (0.48) KMT2AMEN1CHEK2SMAD3ALDH1A1
SCHEMBL1621759 0.85 MAPT (0.41) KMT2AMEN1CHEK2SMAD3ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8283354-B2 Voltage gated sodium and calcium channel inhibitors VERTEX PHARMACEUTICALS INCORPORATED (US) 2012-10-09 US disclosed
US-7928107-B2 Quinazolines useful as modulators of ion channels VERTEX PHARMACEUTICALS INCORPORATED (US) 2011-04-19 US disclosed